PLT 1.39% 73.0¢ plenti group limited

hpv competitors, page-9

  1. 85 Posts.
    Dear all,

    Re Genera's PapType test, it looks to me as if it is a lot further down the track than you think...Gribbles (3rd largest path player in Oz...Sonic are #1) already have it accredited by NATA.

    http://tas.gribbles.com.au/info/general/Document/get/110/documentId/

    Pedigree of WEHI and Prof Ian Frazer (yes the guy that invented a product - Gardisal - that sells >$2.5 billion ...that's billion with a B...per annum) for Genera's test appears pretty robust.

    Also I ask the question which appears fairly reasonable to me...how does one acquire a portfolio of 'world leading HPV patents' for A$210k (1.5m shares @ $0.14)...must be the deal of the century...compare this to the nearly $8.5m in Genera's balance sheet as issued capital.

    Also does PLT's test genotype? I think this is why Sonic/Gribbles have serious interest in Genera's test.

    Just a few thoughts to throw into a value adding conversation
 
watchlist Created with Sketch. Add PLT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.